Deep brain stimulation of the cerebellum for dyskinetic cerebral palsy in young people
Tests safety of cerebellar brain stimulation for dyskinetic cerebral palsy.
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the site
- Trial code
- Registry title
- Cerebellar Deep Brain Stimulation for Movement Disorders in Cerebral Palsy in Children and Young Adults
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 26 Mar 2024
- Expected to end
- 31 Mar 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- DBS
- Record updated
- 5 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and young adults with dyskinetic cerebral palsy caused by a lack of oxygen or blood flow to the brain. They will get deep brain stimulation (DBS) in the cerebellum, a part of the brain.
- Age
- 7 to 25 years at the time of surgery
- Sex
- All sexes
- Disease stage
- Dystonic and/or choreoathetotic cerebral palsy (involuntary twisting or jerky movements), with or without stiff muscles (spasticity). There must be a clear history of brain injury from lack of oxygen or blood flow before movement symptoms, with supporting MRI findings. Gross Motor Function Classification System (GMFCS) Levels II-V. No major cerebellum abnormalities on MRI.
- Earlier treatment
- People must have tried oral medicines without enough relief. Earlier selective dorsal rhizotomy (a spine nerve surgery) is allowed. The patient and family must have asked for DBS surgery.
Main reasons for not taking part
- Blood clotting problems, uncontrolled epilepsy, or severe heart, lung or gut conditions that raise surgery risk
- Pregnancy
- Genetic conditions that look like cerebral palsy
- Severe fixed joint tightness or bone deformities
- Traumatic brain injury, or past infectious or autoimmune brain inflammation (encephalitis); needing diathermy, electroconvulsive therapy or transcranial magnetic stimulation
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Diagnosis of DCP (dystonic and/or choreoathetotic cerebral palsy) with or without comorbid spasticity, with a clear history of hypoxic ischemic brain injury preceding motor symptoms made by a pediatric neurologist, with supporting MRI findings
- Age 7-25 at the time of surgery
- Gross Motor Function Classification System (GMFCS) Levels II-V
- History of appropriate therapy with oral medications with inadequate relief as determined by a movement disorders or pediatric neurologist. Prior history of selective dorsal rhizotomy is allowed
- Patient and family have requested surgical intervention with DBS for their movement disorder
- No gross cerebellar abnormalities observed and reported on structural MRI
- Written informed consent and written/verbal assent for those younger than 18 years of age
- Ability to comply with study follow-up visits for brain recordings, neuroimaging and testing of sham and effective stimulation and clinical assessments
Who cannot take part
- Pregnancy: all women of child-bearing potential will be required to have a negative urine pregnancy test prior to undergoing their surgical procedure
- Requirement of diathermy, electroconvulsive therapy or transcranial magnetic stimulation
- Coagulopathy, uncontrolled epilepsy, severe cardiopulmonary or gastrointestinal conditions, or other medical conditions considered to place the patient at elevated risk for surgical complications
- Exclusion of genetic mimics of cerebral palsy: exclusion of conditions that manifest with a clinical syndrome similar to CP, in the absence of documented risk factors or neuroimaging findings consistent with a history of brain injury or congenital cerebral malformation. Work up may include comparative genomic hybridization (CGH) microarray and multi-gene panel and/or whole genome or whole exome sequencing.)
- Traumatic brain injury (i.e., non-accidental trauma) or history of infectious or autoimmune encephalitis
- Severe fixed contractions and skeletal deformities that would preclude determination of improvement
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 7 and 25 years old?
Where in United States
- University of California San FranciscoSan Francisco, United StatesContact: Marta San Luciano Palenzuela, MDTaking people
About the trial
What the trial wants to find out
The purpose of this study is to test the safety of placing Deep Brain Stimulators (DBS) in a part of the brain called the cerebellum and using electrical stimulation of that part of the brain to treat movement symptoms related to cerebral palsy. Ten children and young adults with dyskinetic cerebral palsy will be implanted with a Medtronic Percept Primary Cell Neurostimulator. We will pilot videotaped automated movement recognition techniques and formal gait analysis, as well as collect and characterize each subject's physiological and neuroimaging markers that may predict hyperkinetic pathological states and their response to therapeutic DBS.
The 2 groups in the trial
- Effective stimulationExisting treatment, for comparison
All participants will receive deep brain stimulation (DBS) in the cerebellum. For the first 20 weeks, every participant undergoes an open label phase to titrate stimulation and determine optimal stimulation settings. Following that phase, each participant starts three cycles of randomized, paired 8-week exposure periods, each pair including effective stimulation followed by sham stimulation, or vice versa. Effective stimulation will be the optimal stimulation settings determined during the open label phase.
Treatment: DBS
- Sham stimulationSham treatment, for comparison
Sham stimulation will be settings at low amplitude (0.1mA) known to be ineffective.
Treatment: DBS
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Cerebellar Deep Brain Stimulation for Severe Combined Movement Disorders and Spasticity in Children and Young Adults With Cerebral Palsy
- Plain-language title
- Deep brain stimulation of the cerebellum for dyskinetic cerebral palsy in young peopleGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06122675, who can take part
- Publications
- Protocol for combined N-of-1 trials to assess cerebellar neurostimulation for movement disorders in children and young adults with dyskinetic cerebral palsy.BMC neurology, 2024
- Protocol for combined N-of-1 trials to assess cerebellar neurostimulation for movement disorders in children and young adults with dyskinetic cerebral palsy.Research square, 2024
- Record updated
- 5 June 2026